cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer
Published 3 years ago • 435 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
2:56
therap: lupsma versus cabazitaxel for prostate cancer
-
2:06
mcrpc: cabazitaxel re-challenge
-
1:17
dr kyriakopoulos on adding cabazitaxel to abiraterone/prednisone in patients with mcrpc
-
4:06
combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
2:37
therap: cabazitaxel versus 177lu-psma-617 for mcrpc
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
7:09
cabazitaxel use in metastatic prostate cancer
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
1:15
updates in the treatment of castration-resistant prostate cancer
-
3:47
cabazitaxel safe and effective in mcrpc
-
2:04
a phase ii trial investigating neoadjuvant abiraterone and cabazitaxel in high-risk prostate cancer
-
5:59
lupsma vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docet...
-
1:29
evaluating the role of sbrt in metastatic castrate-resistant prostate cancer
-
1:33
fih study of arv-110 in metastatic castrate-resistant prostate cancer
-
3:16
counseling patients with mcrpc
-
5:51
lupsma vs cabazitaxel for metastatic castration-resistant prostate cancer
-
1:30
cabazitaxel impacts sequencing strategies in prostate cancer